Reducing Nerve Pain Naturally

Guest Bio: Michael Sugerman, Entrepreneur

Michael Sugerman is an entrepreneurial CEO with a profound interest in the life sciences and pharmaceutical industries. He has a record of building innovative companies with a strong sense of purpose that address unmet needs in the marketplace. This includes his latest endeavor, Kage Apothecare.

Kage is creating a niche portfolio of novel, non-prescription products that improve quality of life and health issues associated with chronic diseases, are based on science and appeal to the therapeutic sensibilities of mainstream physicians.

Kage's distinguishing IP delivers proprietary, therapeutic mixtures of plant based extracts and nutritional ingredients in a softgel. It's lead product is Nervia®, a dietary supplement that modulates specific cytokine and chemokine responses to oxidative stress associated with neuropathic pain as well as up and down regulate a specific set related genes. Nervia® supports peripheral nerve health and joint function in the hands and feet and addresses more than an estimated 50 million Americans who suffer from peripheral neuropathy from a variety of causes.

Prior to Kage, Michael held a variety of leadership positions. He was also the founding Chairman and CEO of Sentrx, one of the world's foremost drug safety companies, tracking and analyzing drug failures and serious and other drug-related adverse events for large pharmaceutical companies Sentrx was acquired by a division of Merck in 2013.

He has worked in clinical trials and the application of technology to medicine. Michael invented and led the development of a medical knowledge-ware company that delivered clinical information from PubMed and other expert sources to practicing physicians at the point of care inside of electronic medical records.

For seven years he served on the Intellectual Property Foundation Board of Directors for Virginia Commonwealth University and its Medical School, working to license out pharmaceutical and other inventions to the marketplace. Michael holds a MPH from the Yale School of Medicine.